← SynDRA
SLC-0111
SynDRA canonical compound SYN0025699 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | CA1 | CA12 | CA2 | CA9 |
|---|
| Mechanism of action | carbonic anhydrase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- CA1 INHIBITOR
- CA12 INHIBITOR
- CA9 INHIBITOR
- carbonic anhydrase inhibitor
Cross-references
Synonyms
- 4-{[(4'-fluorophenyl)carbamoyl]amino}benzenesulfonamide
- NSC-213841
- SLC0111
- U-104
- U104
- U 104
- 1-(4-fluorophenyl)-3-(4-sulfamoylphenyl)urea
- ANM9DBL9JT
- RefChem:183370
- CAIX Inhibitor SLC-0111
- 4-(3-(4-fluorophenyl)ureido)benzenesulfonamide
- 4-{[(4-Fluorophenyl)carbamoyl]amino}benzenesulfonamide
- mst-104
- MFCD00159265
- C13H12FN3O3S
- NSC213841
- Carbonic Anhydrase IX/XII Inhibitor II(U-104)
- 4-{[(4'-Fluorophenyl)Carbamoyl]Amino}Benzenesulfonamide
- 4-[3-(4-Fluorophenyl)ureido]benzenesulfonamide
- 4-((((4-Fluorophenyl)amino)carbonyl)amino)benzenesulfonamide
- 4-[[[(4-Fluorophenyl)amino]carbonyl]amino]benzenesulfonamide
- WWZ
- 3n4b
- UNII-ANM9DBL9JT
- SCHEMBL672955
- 3-(4-FLUOROPHENYL)-1-(4-SULFAMOYLPHENYL)UREA
- orb1306733
- GTPL10149
- EX-A904
- CHEBI:232342
- YJQZNWPYLCNRLP-UHFFFAOYSA-N
- GLXC-06014
- HMS3651H21
- HMS3872E13
- WBI-5111
- BDBM50334354
- EBC-06760
- s2866
- 4-fluorophenylureido-benzenesulfonamide
Look up SLC-0111 in the interactive SynDRA portal →